As of 9:30 AM on the 9th, Celltrion is trading at 285,000 KRW, up 2.7% from the previous day. This represents a 20.0% increase compared to October 22. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net sold 164,758 shares, while foreigners and institutions have net sold 21,238 shares and net bought 159,578 shares, respectively.


On November 6, Celltrion was a market topic due to "strength driven by expectations for a COVID-19 treatment."



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing